Pregnancy outcome in women with vitiligo

Amir Horev, Adi Y. Weintraub, Ruslan Sergienko, Arnon Wiznitzer, Sima Halevy, Eyal Sheiner

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

Background Vitiligo, characterized by destruction of melanocytes, causes a patchy depigmentation of the skin. It has been hypothesized to have an autoimmune pathogenesis. Autoimmune disorders are more common among women and may be associated with adverse pregnancy outcomes, such as recurrent abortions, intrauterine growth restriction (IUGR), and pre-eclampsia. Objective The purpose of this study was to investigate whether patients with vitiligo have increased rates of gestational complications. Methods A retrospective comparative study was undertaken comparing pregnancy complications of patients with and without vitiligo. The population was composed of all singleton deliveries that occurred at the Soroka University Medical Center in Israel during the years 1988-2006. Women lacking prenatal care and multiple gestations were excluded from the study. A multivariable logistic regression model was constructed to control for confounders. Results Of 186,222 singleton deliveries, 79 (0.04%) were patients with vitiligo. Vitiligo was not found to be associated with adverse pregnancy outcomes, including obstetric risk factors, labor characteristics and complications, and birth outcome. Using multivariable analysis, only grand multiparity (above five deliveries) was independently associated with vitiligo (OR=2.01; 95% CI 1.2-3.2; P=0.007). Limitations Retrospective analysis was a limitation. Conclusion Vitiligo is not associated with adverse pregnancy outcomes. Accordingly, patients with vitiligo should not be managed differently from the general obstetric population.

Original languageEnglish
Pages (from-to)1083-1085
Number of pages3
JournalInternational Journal of Dermatology
Volume50
Issue number9
DOIs
StatePublished - 1 Sep 2011
Externally publishedYes

Fingerprint

Dive into the research topics of 'Pregnancy outcome in women with vitiligo'. Together they form a unique fingerprint.

Cite this